Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of ticagrelor effects and plasma concentration after crushed vs non-crushed intake in post-CABG and post–cardiac arrest patients
2013-004191-35Phase 4Completed
- Sponsor
- Ghent University Hospital
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ticagrelor in acute ST-segment elevation myocardial infarction (STEMI) (2 arms), sponsored by Ghent University Hospital. Primary endpoint: Platelet inhibition measured by Platelet Function Analyser. Started Oct 2014; status: completed.
02
Drugs
ticagrelor
03
Conditions
acute ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on 2013-004191-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004191-35.